11 June 2025 Capstan Therapeutics Announces Initiation of Phase 1 Trial of Lead In Vivo CAR-T Therapy, CPTX2309, for Treating Autoimmune Disease read more
10 June 2025 Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serious Diseases read more
28 May 2025 Aktis Oncology Initiates Phase 1b Clinical Trial Of Its Nectin-4- Targeting Radiopharmaceutical Product Candidate, Aky-1189, Across Multiple Tumor Types read more
23 May 2025 Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi read more
2 April 2025 Vida Ventures Taps Industry Heavyweights from JP Morgan and MPM BioImpact to Further Power Leadership Team read more
